Medical News Hubb
Advertisement
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
Medical News Hubb
No Result
View All Result
Home Medicines & Healthy Lifestyle

COVID-19 Destroys the Weakest and Poorest

admin by admin
January 9, 2023
in Medicines & Healthy Lifestyle


COVID-19 has been called the great equalizer, but nothing could be further from the truth. The disease clearly affects certain groups far worse than others, and the countermeasures implemented to quell the outbreak have been a phenomenal boon for wealthy globalists while decimating the livelihood, and perhaps even the will to live, of the average person. As reported by IPS News:1

“According to the latest ILO reports,2 as job losses escalate due to lockdowns, nearly half of the global workforce is at risk of losing livelihoods, access to food and the ability to survive.

The World Economic Forum states that ‘With some 2.6 billion people around the world in some kind of lockdown, we are conducting arguably the largest psychological experiment ever.’3

As governments and corporations tighten political authoritarianism4 and technological surveillance, curtailing privacy and democratic protest, much of humanity is succumbing to anxiety, depression and a sense of powerlessness.”

An ever-growing number of doctors, academics and scientists are now questioning the origin of the virus, the validity of using PCR tests to diagnose “cases,” the usefulness of face masks, the questionable classification of COVID-19 deaths, the suppression of scientifically verified methods of prevention and treatment, and the safety and usefulness of COVID-19 vaccines.



Source link

Previous Post

Physical Activity May Help Reduce Depression Symptoms In Kids: Study

Next Post

Pediatricians recommend obesity drugs for children

Next Post

Pediatricians recommend obesity drugs for children

Recommended

Flu Hospitalizations Drop Amid Signs of an Early Peak

December 17, 2022

Aducanumab, Lecanemab for Early AD: The Clinical Trials That Led to FDA Approval

January 25, 2023

Don't miss it

Pharmaceutical

Strange bedfellows lobby for Medicare obesity-drug coverage

January 26, 2023
Medicines & Healthy Lifestyle

FDA Panel Votes on Rezafungin for Treatment of Candidemia, Invasive Candidiasis

January 26, 2023
Medicines & Healthy Lifestyle

This Cancer Drug Can Increase Longevity, Study Finds

January 26, 2023
News

Something in Breast Milk Helps Protect Babies Against Allergies

January 26, 2023
Pharmaceutical

Merck ends late-stage trial for Keytruda in prostate cancer

January 25, 2023
Medicines & Healthy Lifestyle

Are Seed Oils Behind the Majority of Diseases This Century?

January 25, 2023

© 2022 Medical News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

Newsletter Sign Up

No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

© 2022 Medical News Hubb All rights reserved.